Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradation
Saved in:
Published in | Acta pharmaceutica Sinica. B Vol. 15; no. 4; pp. 2293 - 2294 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier B.V
01.04.2025
Elsevier |
Online Access | Get full text |
Cover
Loading…
Author | Yu, Bin |
---|---|
Author_xml | – sequence: 1 givenname: Bin surname: Yu fullname: Yu, Bin email: yubin@zzu.edu.cn organization: College of Chemistry, Pingyuan Laboratory, Zhengzhou University, Zhengzhou 450001, China |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/40486839$$D View this record in MEDLINE/PubMed |
BookMark | eNp9Uk1r3DAQNSWl-Wj-QA_Fx-RgVx-WP6BQwtKmgYX2kJ7FSB47WmzLlbQL--8r18nSXKqLxMx7b8Sbd5mcTXbCJPlASU4JLT_tcpi9yhlhIic8J0XxJrlgjNKM1wU_O725OE-uvd-ReErCWCXeJecFKeqy5s1FErZ4QAe9mfq0H46z0TBlPL25_7nht9mIrYGAbTocvfV2xCyA6zEsaP1kxsj0Ebt9vNv427SzLl37kTHiqBxMmM7OBjRT2mLvoIVg7PQ-edvB4PH6-b5Kfn37-rj5nm1_3D9s7raZLggPmYqfx44hr5DWVGkKXd3VUPCyproipKtqTjoORFUVlLoVwGtCeSeAQPRI8avkYdVtLezk7MwI7igtGPm3YF0vwQWjB5RIxDJLKNLqoqmIUl2rVKsEBWiFWrS-rFrzXkVbNE7BwfBK9HVnMk-ytwdJGeVVU4uocPOs4OzvPfogR-M1DkN0ye695IyWDW3KoorQj_8OO0152VsEsBWgnfXeYXeCUCKXfMidXPIhl3xIwmXMRyR9XkkYPT8YdNJrg5OOS3aoQzTF_I_-B7xexJA |
Cites_doi | 10.1016/j.apsb.2025.02.037 |
ContentType | Journal Article |
Copyright | 2025 2025 Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. 2025 |
Copyright_xml | – notice: 2025 – notice: 2025 Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. 2025 |
DBID | 6I. AAFTH AAYXX CITATION NPM 7X8 5PM DOA |
DOI | 10.1016/j.apsb.2025.03.044 |
DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 2211-3843 |
EndPage | 2294 |
ExternalDocumentID | oai_doaj_org_article_e055ef25b0dc4970bbfdbbdb51aad5bb PMC12137985 40486839 10_1016_j_apsb_2025_03_044 S2211383525001984 |
Genre | Editorial Commentary |
GroupedDBID | --- --K -05 -0E -SE -S~ 0R~ 1~5 4.4 457 4G. 53G 5VR 5VS 6I. 7-5 92M 9D9 9DE AAEDT AAEDW AAFTH AAIKJ AALRI AAXUO AAYWO ABKZE ABMAC ACGFS ADBBV ADEZE ADRAZ ADVLN AEXQZ AFUIB AGHFR AITUG AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS APXCP BAWUL BCNDV CAJEE CCEZO CIEJG DIK EBS EJD FDB GROUPED_DOAJ GX1 HH5 HYE HZ~ IPNFZ IXB JUIAU KQ8 M41 M48 O-L O9- OK1 Q-- R-E RIG ROL RPM RT5 SES SSZ T8U U1F U1G U5E U5O XH2 ~NG AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION NPM 7X8 5PM |
ID | FETCH-LOGICAL-c403t-b835ef2e37e181bc1af8f8a43681c700f7830f3a0b77a6cd5a38013f5a0a101b3 |
IEDL.DBID | M48 |
ISSN | 2211-3835 |
IngestDate | Wed Aug 27 01:28:12 EDT 2025 Thu Aug 21 18:25:30 EDT 2025 Fri Jul 11 17:07:21 EDT 2025 Mon Jul 21 06:07:15 EDT 2025 Tue Jul 01 04:39:55 EDT 2025 Sat Jun 07 17:02:37 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
License | This is an open access article under the CC BY-NC-ND license. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c403t-b835ef2e37e181bc1af8f8a43681c700f7830f3a0b77a6cd5a38013f5a0a101b3 |
Notes | SourceType-Scholarly Journals-1 content type line 23 ObjectType-Editorial-2 ObjectType-Commentary-1 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.apsb.2025.03.044 |
PMID | 40486839 |
PQID | 3216919647 |
PQPubID | 23479 |
PageCount | 2 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_e055ef25b0dc4970bbfdbbdb51aad5bb pubmedcentral_primary_oai_pubmedcentral_nih_gov_12137985 proquest_miscellaneous_3216919647 pubmed_primary_40486839 crossref_primary_10_1016_j_apsb_2025_03_044 elsevier_sciencedirect_doi_10_1016_j_apsb_2025_03_044 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | April 2025 2025-04-00 2025-Apr 20250401 2025-04-01 |
PublicationDateYYYYMMDD | 2025-04-01 |
PublicationDate_xml | – month: 04 year: 2025 text: April 2025 |
PublicationDecade | 2020 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands |
PublicationTitle | Acta pharmaceutica Sinica. B |
PublicationTitleAlternate | Acta Pharm Sin B |
PublicationYear | 2025 |
Publisher | Elsevier B.V Elsevier |
Publisher_xml | – name: Elsevier B.V – name: Elsevier |
References | Fang, Zhu, Wang, Xia, He, Dong (bib1) 2025; 15 Fang (10.1016/j.apsb.2025.03.044_bib1) 2025; 15 |
References_xml | – volume: 15 start-page: 2156 year: 2025 end-page: 2169 ident: bib1 article-title: GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins publication-title: Acta Pharm Sin B – volume: 15 start-page: 2156 year: 2025 ident: 10.1016/j.apsb.2025.03.044_bib1 article-title: GPC3-mediated lysosome-targeting chimeras (GLTACs) for targeted degradation of membrane proteins publication-title: Acta Pharm Sin B doi: 10.1016/j.apsb.2025.02.037 |
SSID | ssj0000602275 |
Score | 2.3167598 |
SourceID | doaj pubmedcentral proquest pubmed crossref elsevier |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 2293 |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZQT1wQb5aXjIQqKmrhrO16cywRpUIF5ZBKvVl-0qBmE7HpIf-eGXvTZkGCC9e19zEPez6vZz4T8hZALudWJKaaIJjUNjCXtGWikSGMrEo87-B__XZ0ei6_XKiLnaO-MCes0AMXxX2IXKmYauV48HKsuXMpOBecGlkblHM4-0LM21lMlTkYqfEwf7GukacPcEZfMVOSu-yqc7A4rFVmOJVyEJUyef8gOP0JPn_PodwJSif3yb0eTdLjIsUDcie2D8n-tNBRbw7p7La6qjuk-3R6S1S9eUTWZxEcOR9TRL9fbVY4IzJB332eTsQByzUlgEfp1aZbdstFZCVrHHv7yzn-zOqg79nseNIdUMC-tLTDHYu4gEV4G2lmgZi3NCAlRTm96TE5P_k0m5yy_hQG5iUXa-ZAd2CAKHQENOD8yKYmNRaZ60dec550I3gSljut7ZEPygqIeiIpyy1o24knZK9dtvEZoQBvUnJeNfVYygBQwYeQbK2iC76xSVTk_dYKZlXINsw2C-2HQZsZtJnhwoDNKvIRDXXTE4my8wVwH9O7j_mX-1REbc1sesxRsAQ8av7Xl7_Z-oSBAYm7LKDW5XVnRI38Q1jgW5GnxUduPlEiwSFA0oo0A-8ZyDBsaeeXmfQbqff0uFHP_4fUL8hdlKVkIL0ke-uf1_EVgKu1e53H0S-zdiYg priority: 102 providerName: Directory of Open Access Journals – databaseName: Elsevier ScienceDirect Open Access Journals dbid: IXB link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3Nb9MwFLemnbggvikwZCQ0MTGrbmw37nGrGBMaqBKd1Jtlx_YWtKbV0h363-89J-kISBw4xh_Ji9-z_bP93s-EfASQy7kVkSntBZO59czF3DKhpfcjqyJPJ_jff4zPL-W3hVrskWkXC4Nule3Y34zpabRuU4Ztaw7XZTn8mcHaRSCAUIhTNHKCCqlTEN_idLfPwsdIkoeejFieYYU2dqZx87Lr2sEyMVOJ61TK3vyUaPx709TfMPRPb8rfpqezJ-RxiyvpSSP6U7IXqmfkcNYQU2-P6fwhzqo-pod09kBZvX1ONhcBTDpdWESvbrZrHBuZoJ--zqbiiKXoEkCm9GZbr-rVMrDGfxxLF9clbmvVUPZifjKtjyigYNrkQ41lWMJyvAo08UGUFfVITtHc4_SCXJ59mU_PWXsfAyskFxvmoO1CzILIA-ACV4xs1FFb5LAfFTnnMdeCR2G5y3M7LryyAuY_EZXlFlrbiZdkv1pV4TWhAHRidIXS2URKD6Ch8D7aTAXnC22jGJDPnRbMuqHdMJ0_2i-DOjOoM8OFAZ0NyCkqalcSKbNTwur2yrQ2YwJXKL1y3BdyknPnonfOOzWy1ivnBkR1ajY9C4RXlf_8-IfOJgx0TTxvgWZd3dVGZMhEhKG-A_KqsZGdiBKpDgGcDojuWU_vH_o5VXmd6L-RhC-faPXmPwV-Sx7hU-N-9I7sb27vwgEgq417n7rOPSIeI_Q priority: 102 providerName: Elsevier |
Title | Leveraging glypican-3 (GPC3)-mediated lysosome-targeting chimeras (GLTACs) for targeted membrane protein degradation |
URI | https://dx.doi.org/10.1016/j.apsb.2025.03.044 https://www.ncbi.nlm.nih.gov/pubmed/40486839 https://www.proquest.com/docview/3216919647 https://pubmed.ncbi.nlm.nih.gov/PMC12137985 https://doaj.org/article/e055ef25b0dc4970bbfdbbdb51aad5bb |
Volume | 15 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbGeOEF8ZsMmIyEJiZm5Mbxkj4gtFWMARsqUiv1zbJjeytqk9J0EvnvuXOSlcLEAy9-iO3E9t3lPifn7wh5BSCXcy08k5kVLEm1ZcanmokssbanpefhD_7518PTcfJ5IidbpEt31C5gdePWDvNJjZeztz9_1O_B4N-tY7X0ojKw14tlICxNklvkNnimFA31vIX7zZsZCfMwqjGOkb0P0Ed7jubm22z4qkDpv-Gy_oakf0ZW_uaqTu6Ruy3GpEeNUtwnW654QPaGDUl1fUBH6zNX1QHdo8M1fXX9kKzOHKh3SF5EL2b1At-TTNDXH4cDsc_CSRNAqXRWV2VVzh1rYsmxdX45xU9cFbQ9Gx0Nqn0KiJg29dBj7uawNS8cDdwQ04JaJKpocjo9IuOTD6PBKWtzM7A84WLFDKyd87ETqQOMYPKe9pnPNPLZ9_KUc59mgnuhuUlTfZhbqQX4QuGl5hpW24jHZLsoC_eUUAA93ptcZnE_SSwAiNxar2PpjM0z7UVE3nRSUIuGgkN1sWnfFcpMocwUFwpkFpFjFNR1S6TPDhfK5YVqrVE5LnH00nCbJ_2UG-OtMdbIntZWGhMR2YlZtUikQRhwq-k_H_6y0wkFZor_XmBZy6tKiRhZifDYb0SeNDpyPcQEaQ8BqEYk29CejTls1hTTy0AFjoR8aT-TO__f9Rm5gzNoopGek-3V8sq9AKC1MrvhAwWUnybHUH75lu0Ge_oFwiYtwA |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9sgEEdd97C9TPuu98mkqVq1ohADsfPYRuvSLa0iLZXyhsBA66mxozp9yH-_O9tJ503aw14N2Jg77n7A3Q9CPgLI5dyIwFTqBJOJccyGxDCRSuf6RgVen-CfnQ_GF_LbXM13yGiTC4Nhla3tb2x6ba3bJ712NHvLPO_9iGHtIhBAKMQpqbxH7gMaSPD-htP58XajhQ-QJQ9DGbEBwxZt8kwT52WWlYV1YqxqslMpOw6q5vHv-Km_ceif4ZS_-aeTx-RRCyzpUdP3J2THF0_J_rRhpl4f0tldolV1SPfp9I6zev2MrCYedLq-sYheXq-XaByZoJ--TkfigNXpJQBN6fW6Kqty4VkTQI61s6sc97UqqDuZHY2qAwowmDbl0GLhF7AeLzytCSHygjpkp2gucnpOLk6-zEZj1l7IwDLJxYpZGDsfYi8SD8DAZn0T0pAaJLHvZwnnIUkFD8JwmyRmkDllBDhAEZThBkbbihdktygLv0coIJ0QbKbSeCilA9SQORdMrLx1WWqCiMjnjRT0suHd0JuAtJ8aZaZRZpoLDTKLyDEKalsTObPrB-XNpW6VRnuusPfKcpfJYcKtDc5aZ1XfGKesjYjaiFl3VBBelf_z4x82OqFhbuKBCwxreVtpESMVEeb6RuRloyPbLkrkOgR0GpG0oz2df-iWFPlVzf-NLHzJMFWv_rPD78mD8exsoien599fk4dY0sQivSG7q5tb_xZg1sq-q6fRL8VjJxM |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Leveraging+glypican-3+%28GPC3%29-mediated+lysosome-targeting+chimeras+%28GLTACs%29+for+targeted+membrane+protein+degradation&rft.jtitle=Acta+pharmaceutica+Sinica.+B&rft.au=Yu%2C+Bin&rft.date=2025-04-01&rft.pub=Elsevier&rft.issn=2211-3835&rft.eissn=2211-3843&rft.volume=15&rft.issue=4&rft.spage=2293&rft.epage=2294&rft_id=info:doi/10.1016%2Fj.apsb.2025.03.044&rft.externalDocID=PMC12137985 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2211-3835&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2211-3835&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2211-3835&client=summon |